Evidence map›Paper›PMID 26670252›Full record

ArticleToxins2015

Superantigen-Producing Staphylococcus aureus Elicits Systemic Immune Activation in a Murine Wound Colonization Model.

Choon K Kim, Melissa J Karau, Kerryl E Greenwood-Quaintance, Ashenafi Y Tilahun, Ashton Krogman, Chella S David, Bobbi S Pritt, Robin Patel, Govindarajan Rajagopalan

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. [Research progress on the mechanisms of probiotics promoting wound healing].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2024
    Review
  6. HOCl-producing electrochemical bandage for treatingAntimicrobial agents and chemotherapy · 2024
    Article
  7. Article
  8. Antimicrobial polymer-loaded hydrogels for the topical treatment of multidrug-resistant wound biofilm infections.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  9. Article
  10. Advanced therapeutics · 2023
    Article
  11. Dual antimicrobial-loaded biodegradable nanoemulsions for synergistic treatment of wound biofilms.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Photodynamic antimicrobial chemotherapy forInternational journal of nanomedicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Choon K KimDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. schenics77@gmail.com.
Melissa J KarauDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. karau.melissa@mayo.edu.
Kerryl E Greenwood-QuaintanceDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. piper.kerryl@mayo.edu.
Ashenafi Y TilahunDepartment of Immunology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. aytilahun@mmm.com.
Ashton KrogmanDepartment of Immunology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. Krogman.ashton@mayo.edu.
Chella S DavidDepartment of Immunology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. david.chella@mayo.edu.
Bobbi S PrittDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. pritt.bobbi@mayo.edu.
Robin PatelDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. patel.robin@mayo.edu.
Govindarajan RajagopalanDepartment of Immunology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. rajagopalan.govindarajan@mayo.edu.
Mayo Clinic · US

Funding

HLA class II transgenic mouse models for S. aureus infections and superantigensR01AI068741 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI RAJAGOPALAN, GOVINDARAJAN · 2007 to 2016
$3.1M
Novel Combination Therapy for Staphylococcus aureus PneumoniaR21AI101172 · NIAID · MAYO CLINIC ROCHESTER · PI RAJAGOPALAN, GOVINDARAJAN · 2012 to 2013
$425k
NIAID NIH HHS AI101172NIAID NIH HHS AI68741NIAID NIH HHS R01 AI068741NIAID NIH HHS R21 AI101172
6 · The paper itself

Abstract

Staphylococcus aureus, the most common cause of wound infection, produces several exotoxins, including superantigens (SAgs). SAgs are the potent activators of the immune system. Given this unique property, we hypothesized that SAgs produced by S. aureus in wounds would have local, as well as systemic immunologic effects. We tested our hypothesis using a novel staphylococcal skin wound infection model in transgenic mice expressing HLA-DR3. Skin wounds were left uninfected or colonized with S. aureus strains producing SAgs or an isogenic strain not producing any SAg. Animals with wounds challenged with SAg-producing S. aureus had increased morbidity and lower serum IL-17 levels compared to those challenged with the SAg non-producing S. aureus (p = 0.027 and p = 0.032, respectively). At Day 8 following microbial challenge, compared to mice with uninfected wounds, the proportion of Vβ8⁺CD4⁺ T cells was increased, while the proportion of Vβ8⁺CD8⁺ T cells was decreased only in the spleens of mice challenged with SAg-producing S. aureus (p < 0.001). No such changes were measured in mice challenged with SAg non-producing S. aureus. Lungs, livers and kidneys from mice challenged with SAg-producing, but not SAg non-producing, S. aureus showed inflammatory changes. Overall, SAg-mediated systemic immune activation in wounds harboring S. aureus may have clinical implications.

Indexed as

AnimalsAntigens, BacterialCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesInterleukin-17KidneyLiverLungMice, TransgenicSkinSkin DiseasesStaphylococcal InfectionsStaphylococcus aureusSuperantigensWound HealingAntigens, BacterialInterleukin-17SuperantigensHLA class II transgenic miceinflammationskin infectionStaphylococcus aureussuperantigenwound healing

Identifiers

PMID26670252
PMCPMC4690136
OpenAlexW2191605025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.